Rare diseases
Investigational molecules
Locations
Scheeles Vag 2, 171 65 Solna, Sweden
The sponsor concentrates on advancing diagnostic imaging technologies for cancer detection and characterization. Their research portfolio emphasizes the development of novel molecular imaging agents designed to enhance visualization of tumor tissues and improve clinical decision-making in oncology settings.
The organization's work focuses on creating affinity-based imaging compounds that enable precise identification of malignant tissues, supporting more accurate staging and treatment planning for patients with various cancer types.
Affibody AB runs clinical trials in conditions such as HER2 positive breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
